Published by The Medical Letter, Inc. • 1000 Main Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication

   options

 

Select a Newsletter:
Select a year:
ONLINE ARCHIVES - The Medical Letter on Drugs and Therapeutics
These online issues of The Medical Letter are only accessible by registered online subscribers of The Medical Letter. Reading these articles requires Adobe Acrobat Reader.

For Non-Subscribers:
Subscribe online now and receive immediate online access
Purchase any single issue
The Medical Letter on Drugs and Therapeutics - 2003
January February
January 6; 45 (1147) : 1-4
Smallpox Vaccine;
OTC Loratadine (Claritin)
January 20; 45 (1148) : 5-8
Augmentin XR;
Oxaliplatin (Eloxatin) for Advanced Colon Cancer
February 3; 45 (1149) : 9-12
Teriparatide (Forteo) for Osteoporosis;
Atomoxetine (Strattera) for ADHD
February 17; 45 (1150) : 13-16
Buprenorphine: An Alternative to Methadone;
Aripiprazole (Abilify) for Schizophrenia
March April
March 3; 45 (1151) : 17-20
Three New Drugs for Hyperlipidemia;
Peginterferon Alfa-2a (Pegasys) for Chronic Hepatitis C
March 17; 45 (1152) : 21-24
Montelukast (Singulair) for Allergic Rhinitis;
Anastrozole (Arimidex) vs. Tamoxifen for Treatment of Early Breast Cancer;
Drug-Eluting Stents
March 31; 45 (1153) : 25-28
Adalimumab (Humira) for Rheumatoid Arthritis;
Pneumococcal Vaccine (Prevnar) for Otitis Media
April 14; 45 (1154) : 29-32
Nitazoxanide (Alinia) -- A New Anti-Protozoal Agent;
Alefacept (Amevive) for Treatment of Psoriasis
April 28; 45 (1155) : 33-36
Eletriptan (Relpax) for Migraine;
Insulin-Sensitizing Drugs for Polycystic Ovary Syndrome
May June
May 12; 45 (1156) : 37-40
Pediarix -- A Combined Vaccine for Infants;
Oxybutynin Transdermal (Oxytrol) for Overactive Bladder;
Eplerenone (Inspra)
May 26; 45 (1157) : 41-44
Insect Repellents;
Ophthalmic Cyclosporine (Restasis) for Dry Eye Disease;
Xanax XR for Panic Disorder
June 9; 45 (1158) : 45-48
Antioxidant Vitamins and Zinc for Macular Degeneration;
Drug Interactions
June 23; 45 (1159) : 49-52
Enfuvirtide (Fuzeon) for HIV Infection;
Blue Light (ClearLight) for Acne Vulgaris;
Prilosec, Nexium and Stereoisomers
July August
July 7; 45 (1160) : 53-56
Are SSRIs Safe for Children?;
Rapid Tests for HIV Infections;
Pegvisomant (Somavert) for Acromegaly
July 23; 45 (1161) : 57-60
Bortezomib (Velcade) for Multiple Myeloma;
Prevention and Treatment of Heat Injury;
Index
August 4; 45 (1162) : 61-64
Over-the-counter Omeprazole (Prilosec OTC);
Aprepitant (Emend) for Prevention of Nausea and Vomiting Due to Cancer Chemotherapy;
Hypoglycemia and Hyperglycemia with Fluoroquinolones
August 18; 45 (1163) : 65-68
FluMist: An Intranasal Live Influenza Vaccine;
Omalizumab (Xolair): An Anti-IgE Antibody for Asthma
September October
September 1; 45 (1164) : 69-72
Minimal Surgery for Treatment of GERD;
Testim and Striant -- Two New Testosterone Products
September 15; 45 (1165) : 73-76
Memantine for Alzheimer's Disease;
Agalsidase Beta (Fabrazyme) for Fabry Disease;
Azelaic Acid (Finacea) for Rosacea
September 29; 45 (1166) : 77-80
Vardenafil (Levitra) for Erectile Dysfunction;
Influenza Prevention 2003-2004
(Superseded by issue 1321 - 9/21/09)
October 13; 45 (1167) : 81-84
Rosuvastatin - A New Lipid-lowering Drug;
Lp-PLA2: A New Marker of Vascular Risk;
Index
October 27; 45 (1168) : 85-88
Lowering Plasma Homocysteine;
Iodine-131 Tositumomab (Bexxar) for Treatment of Lymphoma;
α-L-iduronidase (Laronidase; Aldurazyme)
November December
November 10; 45 (1169) : 89-92
Growth Hormone for Normal Short Children;
Atazanavir (Reyataz) and Emtricitabine (Emtriva) for HIV Infection
November 24; 45 (1170) : 93-96
Which SSRI?;
Tattoo Removal
December 8; 45 (1171) : 97-100
Efalizumab (Raptiva) for Treatment of Psoriasis;
New Glucose-Monitoring Devices;
Safety of Canadian Drugs
December 22; 45 (1172) : 101-104
Tadalafil (Cialis) for Erectile Dysfunction;
Choice of an Antipsychotic
 
Subscribe online now and receive immediate online access
 
© 2010 The Medical Letter, Inc. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.